Clinical application of CYP2C19 pharmacogenetics toward more personalized medicine
More than 30 years of genetic research on the CYP2C19 gene alone has identified approximately 2,000 reference single nucleotide polymorphisms (rsSNPs) containing 28 registered alleles in the P450 Allele Nomenclature Committee and the number continues to increase. However, knowledge of CYP2C19 SNPs r...
Main Author: | Su-Jun eLee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-02-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2012.00318/full |
Similar Items
-
THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01) -
Variation in CYP2A6 Activity and Personalized Medicine
by: Julie-Anne Tanner, et al.
Published: (2017-12-01) -
Pharmacogenetic testing revisited: 5′nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19
by: Larsen JB, et al.
Published: (2017-04-01) -
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy
by: M I Savelyeva, et al.
Published: (2017-06-01) -
Pharmacogenetic Tests in the Nephrological Clinic
by: D.D. Ivanov, et al.
Published: (2016-10-01)